Asia Pacific Overactive Bladder Treatment Market
The Asia Pacific Overactive Bladder Treatment Market size was valued at US$ 871.48 Mn in 2022 and is projected to reach US$ 1,082.25 Mn by 2028, growing at a CAGR of 3.7% during 2022 - 2028.
Report Coverage
- Pharmacotherapy: Anticholinergics, Mirabegron, Botox, Neurostimulation, Intravesical Instillation
- Disease Type: Idiopathic Overactive Bladder and Neurogenic Bladder
US$ 871.48 Mn
Market size in 2022
US$ 1,082.25 Mn
Market Size by 2028
3.7%
CAGR, 2022 - 2028
2023-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Overactive Bladder Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Overactive Bladder Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Overactive Bladder Treatment Market Regional Analysis
6.2 Asia Pacific Overactive Bladder Treatment Market Revenue 2020-2028 (US$ Million)
6.3 Asia Pacific Overactive Bladder Treatment Market Forecast Analysis
7. Asia Pacific Overactive Bladder Treatment Market Analysis – by Pharmacotherapy
7.1 Anticholinergics
- 7.1.1 Overview
- 7.1.2 Anticholinergics: Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Mirabegron
- 7.2.1 Overview
- 7.2.2 Mirabegron: Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Botox
- 7.3.1 Overview
- 7.3.2 Botox: Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Neurostimulation
- 7.4.1 Overview
- 7.4.2 Neurostimulation: Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.5 Intravesical Instillation
- 7.5.1 Overview
- 7.5.2 Intravesical Instillation: Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Asia Pacific Overactive Bladder Treatment Market Analysis – by Disease Type
8.1 Idiopathic Overactive Bladder and Neurogenic Bladder
- 8.1.1 Overview
- 8.1.2 Idiopathic Overactive Bladder and Neurogenic Bladder : Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Asia Pacific Overactive Bladder Treatment Market – Asia-Pacific Analysis
9.1 Overview
9.2 Asia-Pacific- 9.2.1 Asia Pacific Overactive Bladder Treatment Market Breakdown, by Key Country, 2023 and 2028 (%)
- 9.2.1.1 Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 China: Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 China: Asia Pacific Overactive Bladder Treatment Market Breakdown, by Pharmacotherapy
- 9.2.1.1.2 China: Asia Pacific Overactive Bladder Treatment Market Breakdown, by Disease Type
- 9.2.1.2 India: Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 India: Asia Pacific Overactive Bladder Treatment Market Breakdown, by Pharmacotherapy
- 9.2.1.2.2 India: Asia Pacific Overactive Bladder Treatment Market Breakdown, by Disease Type
- 9.2.1.3 Japan: Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Japan: Asia Pacific Overactive Bladder Treatment Market Breakdown, by Pharmacotherapy
- 9.2.1.3.2 Japan: Asia Pacific Overactive Bladder Treatment Market Breakdown, by Disease Type
- 9.2.1.4 Australia: Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Australia: Asia Pacific Overactive Bladder Treatment Market Breakdown, by Pharmacotherapy
- 9.2.1.4.2 Australia: Asia Pacific Overactive Bladder Treatment Market Breakdown, by Disease Type
- 9.2.1.5 Rest of Asia-Pacific : Asia Pacific Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Overactive Bladder Treatment Market Breakdown, by Pharmacotherapy
- 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Overactive Bladder Treatment Market Breakdown, by Disease Type
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 AbbVie Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Alembic Pharmaceuticals Limited
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Astellas Pharma Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Endo PHARMACEUTICALS Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Hisamitsu Pharmaceutical Co., Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Medtronic Plc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Pfizer Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Teva PHARMACEUTICAL Industries Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
